RETRACTED: Bivalent Gadolinium Ions Forming Injectable Hydrogels for Simultaneous In Situ Vaccination Therapy and Imaging of Soft Tissue Sarcoma
Authors:
Open Access
- 31 August 2023
- journal article
- retracted article
- Published by Wiley in Advanced Healthcare Materials
- Vol. 12 (26) , e2300877
Abstract
Doxorubicin (DOX) is the classic soft tissue sarcomas (STS) first‐line treatment drug, while dose‐dependent myelosuppression and cardiotoxicity limit its application in clinic. This research intends to apply DOX, which is also an inducer of immunogenic cell death as a part for “in situ vaccination” and conjointly uses PD‐1 inhibitors to enhance antitumor efficacy. In order to achieve the sustained vaccination effect and real‐time monitoring of distribution in vivo, the in situ forming and injectable hydrogel platform with the function of visualization is established for local delivery. The hydrogel platform is synthesized by hyaluronic acid‐dopamine coordinated with gadolinium ions (Gd 2+ ). Gd 2+ provides the ability of magnetic resonance imaging, meanwhile further cross‐linking the hydrogel network. Experiments show excellent ability of sustained release and imaging tracking for the hydrogel platform. In mouse STS models, the “in situ vaccination” hydrogels show the best effect of inhibiting tumor growth. Further analysis of tumor tissues show that “in situ vaccination” group can increase T cell infiltration, promote M1‐type macrophage polarization and block elevated PD‐1/PD‐L1 pathway caused by DOX. These results are expected to prove the potential for synthesized hydrogels to achieve a universal platform for “in situ vaccination” strategies on STS treatments.Keywords
Funding Information
- National Natural Science Foundation of China (81972192)
- National Natural Science Foundation of China (82272852)
This publication has 52 references indexed in Scilit:
- The indications and efficacy of conventional chemotherapy in primary and recurrent sarcomaJournal of Surgical Oncology, 2015
- Doxorubicin-based adjuvant chemotherapy in soft tissue sarcoma: pooled analysis of two STBSG-EORTC phase III clinical trialsAnnals of Oncology, 2014
- Self-assembled micellar nanocomplexes comprising green tea catechin derivatives and protein drugs for cancer therapyNature Nanotechnology, 2014
- Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trialThe Lancet Oncology, 2014
- A long-acting formulation of a polypeptide drug exenatide in treatment of diabetes using an injectable block copolymer hydrogelBiomaterials, 2013
- Immunogenic Cell Death in Cancer TherapyAnnual Review of Immunology, 2013
- Hydrogels for biomedical applicationsAdvanced Drug Delivery Reviews, 2012
- Iron-Clad Fibers: A Metal-Based Biological Strategy for Hard Flexible CoatingsScience, 2010
- Soft-Tissue Sarcomas in AdultsNew England Journal of Medicine, 2005
- Resonance Raman Studies of Catecholate and Phenolate Complexes of Recombinant Human Tyrosine HydroxylaseBiochemistry, 1995